PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system

Julia A. Beaver, John P. Gustin, Kyung H. Yi, Anandita Rajpurohit, Matthew Thomas, Samuel F. Gilbert, D. Marc Rosen, Ben Ho Park, Josh Lauring

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system'. Together they form a unique fingerprint.

Medicine & Life Sciences